Stock Specific Views:

Divis Lab: Investors can buy this stock in stages. EPS for FY 14 is expected around 60-62. We can expect 30% appreciation from the current levels in one year.

Financial Tech and MCX: These two stocks are sold off with volumes after the subdued start of MCX-SX. At present, no investment call.

Natco Pharma: Stock may continue to consolidate for some more time. However, it is likely to witness 25-30% appn in one year.

Private Sector Banks: Private Sector Bank stocks could continue to outperform the market. Investors may buy them in stages for possible 12-month targets of Hdfc Bank(825), Yes Bank(600), IndusIndBk(525), KVB(725), ING Vysya(680), Axis(1650) etc.,

L&T Finance: Investors may start accumulating this stock from around 70 levels.

UltraTech: Inspite of rich valuations, this stock could continue to outperform other cement frontline stocks.

McDowell: There were rumours that some banks with whom these stocks have been pledged would sell the pledged stocks in the market. Though long term prospects appear to be very good under the new management of Diego Corp, in short-term, the stock could be volatile till it successfully completes open offer etc., 

* stock specifics originated by mr jagadeswera rao